NASDAQ:ATHX
Delisted

Athersys Stock News

etoro logo Buy ATHX
*Your capital is at risk
$0.0135
+0 (+0%)
At Close: Apr 05, 2024
CLEVELAND--( BUSINESS WIRE )--Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today its participation in
Gainers Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares climbed 212.8% to close at $12.51 on Wednesday after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimac

Nasdaq Drops 200 Points; Meta Platforms Shares Jump

07:24pm, Wednesday, 09'th Nov 2022 Benzinga
U.S. stocks traded lower toward the end of trading , with the Nasdaq Composite dropping 200 points on Wednesday. The Dow traded down 1.44% to 32,684.65 while the NASDAQ fell 1.89% to 10,416.00. The S&
Gainers Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares jumped 219% to $12.80 after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $

Crude Oil Down Over 2%; Outset Medical Shares Spike Higher

05:19pm, Wednesday, 09'th Nov 2022 Benzinga
U.S. stocks traded lower midway through trading as investors focused on the outcome of the midterm elections. The Dow traded down 0.64% to 32,950.16 while the NASDAQ fell 0.76% to 10,535.77. The S&P 5
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. TaskUs, Inc. (NAS
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast ca
Gainers Ocuphire Pharma, Inc. (NASDAQ: OCUP) shares rose 27.8% to $2.67 in pre-market trading. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) surged 61.4% to close at $0.92 after jumping 15% on Thursday. Nuva
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX) will be hosting a conference call on Thursday, November 10, 2022, at 4:30 PM Eastern Time to review its third quarter 2022 financial results.

Athersys: Is Big Pharma Sleeping At The Wheel?

11:43pm, Wednesday, 05'th Oct 2022
Due to an extended downtrend in Athersys stock price due largely to a declining cash position, Athersys currently trades at a market cap near $24 million. The current valuation is miniscule when compa
Losers   KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) shares dipped 58.9% to close at $5.85 on Tuesday after the company announced it terminated the KOMPLETE phase 2 clinical trial for KVD824 for
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. Connexa Sports Technologies Inc. (NASDAQ: CNXA) gained 96% to $0.57. CONNEXA recently announced a
U.S. stocks traded higher, with the Dow Jones gaining more than 700 points on Tuesday. Here are some big stocks recording losses in today’s session. KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) s
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today their participation in
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE